 |
 |
|
|
RESÚMENES OCTUBRE 2005 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Requiere estar conectado a internet.
Haga un click en la información del journal)
Mixed Hypomania in 908 Patients With Bipolar Disorder Evaluated
Prospectively in the Stanley Foundation Bipolar Treatment Network. A Sex-Specific
Phenomenon
Trisha
Suppes, Jim Mintz, Susan L. McElroy, Lori L. Altshuler, Ralph W. Kupka, Mark A.
Frye, Paul E. Keck, Jr, Willem A. Nolen, Gabriele S. Leverich,; Heinz Grunze,
A. John Rush, Robert M. Post
Arch Gen Psychiatry. 2005;62:1089-1096
Epidemiology of Major Depressive Disorder. Results From the
National Epidemiologic Survey on Alcoholism and Related Conditions
Deborah
S. Hasin, Renee D. Goodwin, Frederick S. Stinson, Bridget F. Grant
Arch Gen Psychiatry. 2005;62:1097-1106
Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials
Andrea Cipriani, Heather Pretty, Keith Hawton, and John R. Geddes
Am J Psychiatry 162:1805-1819, October 2005
Premorbid Intellectual Functioning in Bipolar Disorder and Schizophrenia: Results From a Cohort Study of Male Conscripts
Jari Tiihonen, Jari Haukka, Markus Henriksson, Mary Cannon, Tuula
Kieseppä, Ilmo Laaksonen, Juhani Sinivuo, and Jouko Lönnqvist
Am J Psychiatry
162:1904-1910, October 2005
Amygdala Response in Patients With Acute PTSD to Masked and Unmasked Emotional Facial Expressions
Jorge L. Armony, Vincent Corbo, Marie-Hélène Clément, and Alain Brunet
Am J Psychiatry 162:1961-1963, October 2005
ATSUSHI ICHIMURA, HIDEO MATSUMOTO, TAKAYUKI AOKI,
HIDEHIRO ANDOH, HIROSHI YANO, YOSHIHIDE NAKAGAWA, ISOTOSHI YAMAMOTO, AND SADAKI
INOKUCHI
Psychiatry and Clinical Neurosciences. Volume
59 Issue 5 Page 590 - October 2005
FRANCO BENAZZI
Psychiatry and Clinical Neurosciences. Volume
59 Issue 5 Page 570 - October 2005
KOUNOSUKE TSUCHIYAMA, HARUO NAGAYAMA, KUMIKO
YAMADA, KOICHI ISOGAWA, SATOMI KATSURAGI, AND AKIO KIYOTA
Psychiatry and Clinical Neurosciences. Volume
59 Issue 5 Page 546 - October 2005
Venlafaxine extended-release capsules in panic disorder. Flexible-dose, double-blind, placebo-controlled study
JACQUES BRADWEJN, ANTTI AHOKAS, DAN J. STEIN, ELISEO SALINAS, GERARD
EMILIEN, TIMOTHY WHITAKER
The British Journal of Psychiatry (2005) 187: 352-359
RUSSELL C. DALE, ISOBEL HEYMAN, GAVIN GIOVANNONI, ANDRE W J. CHURCH
The British Journal of Psychiatry (2005) 187: 314-319
Can J Psychiatry 2005;50:660–666
Phenytoin:
an anti-bipolar anticonvulsant?
Bersudsky Y
Int J Neuropsychopharmacol. 2005 Oct 5;:1-6 [Epub
ahead of print]
Monika E.
Kolodziej, Margaret L. Griffin, Lisa M. Najavits, Michael W. Otto, Shelly F.
Greenfield and Roger D. Weiss
Drug and Alcohol Dependence. Volume 80, Issue 2, 1
November 2005, Pages 251-257
Incidence and risk factors for depression and
anxiety disorders: Results from a 34-year longitudinal Swedish cohort study
G. Samuelsson, C.
McCamish-Svensson, B. Hagberg, G. Sundström, Ove Dehlin
Aging & Mental Health. Volume 9, Number 6 /
November 2005: 571 - 575
Physical health and mental disorder in elderly
suicide: A case-control study
Michel Préville,
Réjean Hébert, Richard Boyer, Gina Bravo, Monique Seguin
Aging & Mental Health. Volume 9, Number 6 /
November 2005: 576 - 584
Comparison
of efficacy and safety of milnacipran and fluoxetine in Korean patients with
major depression
Lee MS, Ham BJ, Kee BS, Kim
JB, Yeon BK, Oh KS, Oh BH, Lee C, Jung HY, Chee IS, Choe BM, Paik IH
Curr Med Res Opin. 2005 Sep;21(9):1369-76
Paroxetine
serum concentrations in depressed patients and response to treatment
Gilles M, Deuschle M,
Kellner S, Shams M, Krumm B, Hartter S, Heuser I, Hiemke C
Pharmacopsychiatry. 2005 May;38(3):118-21
Anxiety and
depression 3 years following stroke: Demographic, clinical, and psychological
predictors
Val Morrison, Beth
Pollard, Marie Johnston and Ron MacWalter
Journal of Psychosomatic Research. Volume 59, Issue 4,
October 2005, Pages 209-213
Depressive
symptoms and the regulation of proinflammatory cytokine expression in patients
with coronary heart disease
Gregory E. Miller,
Kenneth E. Freedland and Robert M. Carney
Journal of Psychosomatic Research. Volume 59, Issue 4,
October 2005, Pages 231-236
Prevalence, Correlates, and Comorbidity of Bipolar I Disorder and Axis I and II Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions
Bridget F. Grant,
Frederick S. Stinson, Deborah S. Hasin, Deborah A. Dawson, S. Patricia Chou, W.
June Ruan, and Boji Huang
J Clin Psychiatry 2005;66:1205-1215
Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder
Jeffrey S. Simon,
Charles B. Nemeroff
J Clin Psychiatry 2005;66:1216-1220
Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder
George I.
Papakostas, Timothy J. Petersen, Gustavo Kinrys, Alana M. Burns, John J.
Worthington III, Jonathan E. Alpert, Maurizio Fava, and Andrew A. Nierenberg
J Clin Psychiatry 2005;66:1326-1330
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance
Richard C. Shelton,
Douglas J. Williamson, Sara A. Corya, Todd M. Sanger, Luann E. Van Campen,
Michael Case, Susan D. Briggs, and Gary D. Tollefson
J Clin Psychiatry 2005;66:1289-1297
Paroxetine Response and Tolerability Among Ethnic Minority Patients With Mood or Anxiety Disorders:A Pooled Analysis
Peter P. Roy-Byrne,
Philip Perera, Cornelius D. Pitts, and Jacquie A. Christi
J Clin Psychiatry 2005;66:1228-1233
Linda L. Carpenter,
Nada Milosavljevic, Jordan M. Schecter, Audrey R. Tyrka, and Lawrence H. Price
J Clin Psychiatry 2005;66:1234-1238
A 24-Week Randomized, Double-Blind, Placebo-Controlled Study of Escitalopram for the Prevention of Generalized Social Anxiety Disorder
Stuart A.
Montgomery, Rico Nil, Natalie Dürr-Pal, Henrik Loft, and Jean-Philippe
Boulenger
J Clin Psychiatry 2005;66:1270-1278
Randomized Trial of Sertraline Versus Venlafaxine XR in Major Depression: Efficacy and Discontinuation Symptoms
Aytekin Sir,
Russell F. D'Souza, Sukru Uguz, Tom George, Simavi Vahip, Malcolm Hopwood,
Andrew J. Martin, William Lam, and Tal Burt
J Clin Psychiatry 2005;66:1312-1320
Adjunctive Risperidone in Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Olga
Brawman-Mintzer, Rebecca G. Knapp, and Paul J. Nietert
J Clin Psychiatry 2005;66:1321-1325
Mustafa M. Husain, A. John Rush, Harold A. Sackeim, Stephen R.
Wisniewski, Shawn M. McClintock, Nicoletta Craven, Joel Holiner, Jeff R.
Mitchell, G. K. Balasubramani, and Robert Hauge
Am J Geriatr Psychiatry
13:852-860, October 2005
Siegfried Kasper, Hans de Swart, and Henning Friis Andersen
Am
J Geriatr Psychiatry 13:884-891, October 2005
Atypical
antipsychotics for bipolar disorder
Yatham LN
Psychiatr Clin North Am. 2005 Jun;28(2):325-47
Anticonvulsants
in bipolar disorder
Singh V, Muzina DJ,
Calabrese JR
Psychiatr Clin North Am.
2005 Jun;28(2):301-23
Rehospitalization
Rates of Patients With Bipolar Disorder Discharged on a Mood Stabilizer Versus
a Mood Stabilizer Plus an Atypical or Typical Antipsychotic
Patel NC, Crismon ML,
Pondrom M
J Behav Health Serv Res. 2005
October/November/December;32(4):438-445
Possible structural abnormality of the brainstem in unipolar depressive illness: a transcranial ultrasound and diffusion tensor magnetic resonance imaging study
J D Steele, M E Bastin, J M Wardlaw and K P Ebmeier
Journal of Neurology, Neurosurgery, and Psychiatry
2005;76:1510-1515
Gao K, Calabrese JR
Bipolar Disord 2005: 7 (Suppl. 5): 13
Stabilizing the stabilizer: group psychoeducation enhances the stability
of serum lithium levels
Colom F, Vieta E, Sánchez-Moreno J, Martínez-Arán
A, Reinares M, Goikolea JM, Scott J
Bipolar Disord 2005: 7 (Suppl. 5): 32
Oxcarbazepine add-on in the treatment of refractory
bipolar disorder
Pratoomsri W, Yatham LN, Sohn C-H, Solomons K, Lam
RW
Bipolar Disord 2005: 7 (Suppl. 5): 37
Olley AL, Malhi GS, Bachelor J, Cahill CM, Mitchell
PB, Berk M
Bipolar Disord 2005: 7 (Suppl 5): 43
Strategies for
managing antidepressant-induced sexual dysfunction: Systematic review of
randomised controlled trials
Matthew J. Taylor,
Lisa Rudkin and Keith Hawton
Journal
of Affective Disorders. Volume 88, Issue 3, November 2005, Pages 241-254
A review of the
efficacy of transcranial magnetic stimulation (TMS) treatment for depression,
and current and future strategies to optimize efficacy
Colleen K. Loo and
Philip B. Mitchell
Journal
of Affective Disorders. Volume 88, Issue 3, November 2005, Pages 255-267
Efficacy of
pharmacotherapy in depressed patients with and without personality disorders: A
systematic review and meta-analysis
Simone Kool, Robert
Schoevers, Saskia de Maat, Rien Van, Pieter Molenaar, Aukje Vink and Jack
Dekker
Journal
of Affective Disorders. Volume 88, Issue 3, November 2005, Pages 269-278
Lancet Neurology 2005; 4:781-786
Revisiting
Depressive-Prone Bipolar Disorder: Polarity of Initial Mood Episode and Disease
Course Among Bipolar I Systematic Treatment Enhancement Program for Bipolar
Disorder Participants
Roy H. Perlis,
Melissa P. Delbello, Sachiko Miyahara, Stephen R. Wisniewski, Gary S. Sachs,
Andrew A. Nierenberg and STEP-BD investigators
Biological Psychiatry. Volume 58, Issue 7, 1 October 2005, Pages
549-553
An overview of
findings of the Stanley Foundation Bipolar Network (SFBN) and the Bipolar
Collaborative Network (BCN): A focus on anticonvulsants
Post R
Relative
antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions
Thase ME, Entsuah R,
Cantillon M, Kornstein SG
J Womens Health (Larchmt). 2005 Sep;14(7):609-16
Mental health
among Hispanics and Caucasians: risk and protective factors contributing to
prevalence rates of psychiatric disorders
Annya Hernandez, E.
Ashby Plant, Natalie Sachs-Ericsson and Thomas E. Joiner, Jr.
Journal
of Anxiety Disorders. Volume 19, Issue 8, 2005, Pages 844-860
Mirtazapine-induced
arthralgia
Passier A, van Puijenbroek
E
Br J Clin Pharmacol. 2005 Nov;60(5):570-572
A
randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus
citalopram (20 mg/day) in primary care patients with major depressive disorder
Colonna L, Andersen HF,
Reines EH
Curr Med Res Opin. 2005 Oct;21(10):1659-68
Initial
symptoms of manic relapse in manic or mixed-manic bipolar disorder: Post hoc
analysis of patients treated with olanzapine or lithium
Houston JP, Lipkovich IA,
Ahl J, Rotelli MD, Baker RW, Bowden CL
J Psychiatr Res. 2005 Oct 14; [Epub ahead of print]
Thyroid
autoimmunity, depression and anxiety; are there any connections? An epidemiological
study of a large population
Anne Engum, Trine
Bjøro, Arnstein Mykletun and Alv A. Dahl
Journal of Psychosomatic Research. Volume 59, Issue 5,
November 2005, Pages 263-268
Use of polypharmacy and self-reported mood in
outpatients with bipolar disorder
Mazda Adli, Peter C
Whybrow, Paul Grof, Natalie Rasgon, Laszlo Gyulai, Christopher Baethge, Tasha
Glenn, Michael Bauer
Relationship between serum valproate and lithium
levels and efficacy and tolerability in bipolar maintenance therapy
Paul E. Keck,
Charles L. Bowden, Jane M. Meinhold, Laszlo Gyulai, Thomas J. Prihoda, Jeffrey
D. Baker, Patricia J. Wozniak
Divalproex for the treatment of posttraumatic
stress disorder: a retrospective chart review
Lori L. Davis,
Sandra M. Ambrose, Jason M. Newell, Elizabeth Waldrop, Marshall Cates, L
Charles Ward
Christopher
Baethge, Holger Blumentritt, Anne Berghöfer, Tom Bschor, Tasha Glenn, Mazda
Adli, Peter Schlattmann, Michael Bauer, Reinhard Finke
J Psychiatry Neurosci2005;30(6):423-7
Francesco Gambi, Domenico De Berardis, Daniela Campanella, Alessandro
Carano, Gianna Sepede, Gabriele Salini, Daniela Mezzano, Alessandra Cicconetti,
Laura Penna, Rosa Maria Salerno, Filippo Maria Ferro
Journal
of Psychopharmacology, Vol. 19, No. 5, 483-487 (2005)
Antidepressant
response and well-being in pre-, peri- and postmenopausal women with major
depressive disorder treated with fluoxetine
Cassano P, Soares CN, Cusin
C, Mascarini A, Cohen LS, Fava M
Psychother Psychosom. 2005;74(6):362-5
Lack
of Efficacy of the Substance P (Neurokinin(1) Receptor) Antagonist Aprepitant
in the Treatment of Major Depressive Disorder
Keller M, Montgomery S,
Ball W, Morrison M, Snavely D, Liu G, Hargreaves R, Hietala J, Lines C, Beebe
K, Reines S
Biol Psychiatry. 2005 Oct 21; [Epub ahead of print]
Transcranial
magnetic stimulation in treatment-resistant depressed patients: A double-blind,
placebo-controlled trial
David Rossini,
Adelio Lucca, Raffaella Zanardi, Lorenzo Magri and Enrico Smeraldi
Psychiatry Research. Volume 137, Issues 1-2, 15 November 2005,
Pages 1-10
A three-year
follow-up study of patients with the respiratory subtype of panic disorder
after treatment with clonazepam
Antonio E. Nardi,
Alexandre M. Valença, Isabella Nascimento, Fabiana L. Lopes, Marco A.
Mezzasalma, Rafael C. Freire, André B. Veras, Walter A. Zin and Marcio Versiani
Psychiatry Research. Volume 137, Issues 1-2, 15 November 2005,
Pages 61-70